Raphael Pharmaceutical Inc financial statements
Raphael Pharmaceutical Inc's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Net income | −USD 1.28M | 10-K |
| Cash and equivalents | USD 45K | 10-Q |
Raphael Pharmaceutical Inc financials on 6ix · Raphael Pharmaceutical Inc on 6ix